Perdagangan Natus - NTUS CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | - | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.030779% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | -0.013666% | ||||||||
Waktu biaya inap | 22:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | N/A |
Open* | N/A |
1-Year Change* | N/A |
Day's Range* | N/A |
52 wk Range | 20.90-33.93 |
Average Volume (10 days) | N/A |
Average Volume (3 months) | 8.13M |
Market Cap | 1.14B |
P/E Ratio | 88.30 |
Shares Outstanding | 34.58M |
Revenue | 478.30M |
EPS | 0.37 |
Dividend (Yield %) | N/A |
Beta | 0.23 |
Next Earnings Date | Aug 3, 2022 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|
Natus Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 381.892 | 500.97 | 530.891 | 495.175 | 415.684 | 473.438 |
Revenue | 381.892 | 500.97 | 530.891 | 495.175 | 415.684 | 473.438 |
Cost of Revenue, Total | 146.959 | 219.756 | 226.876 | 203.467 | 192.753 | 200.258 |
Gross Profit | 234.933 | 281.214 | 304.015 | 291.708 | 222.931 | 273.18 |
Total Operating Expense | 326.632 | 492.253 | 555.453 | 510.841 | 435.877 | 449.659 |
Selling/General/Admin. Expenses, Total | 135.711 | 200.59 | 207.279 | 188.758 | 156.395 | 170.667 |
Research & Development | 33.443 | 51.822 | 61.482 | 58.733 | 61.296 | 58.006 |
Depreciation / Amortization | 8.983 | 19.171 | 22.585 | 15.144 | 15.224 | 15.129 |
Unusual Expense (Income) | 1.536 | 0.914 | 37.231 | 44.739 | 10.209 | 5.599 |
Operating Income | 55.26 | 8.717 | -24.562 | -15.666 | -20.193 | 23.779 |
Interest Income (Expense), Net Non-Operating | -0.474 | -3.643 | -7.26 | -5.456 | -1.657 | -3.742 |
Other, Net | 0.117 | 0.076 | -0.438 | -0.135 | -0.215 | -0.682 |
Net Income Before Taxes | 54.903 | 5.15 | -32.26 | -21.257 | -22.065 | 19.355 |
Net Income After Taxes | 42.594 | 0.207 | -14.335 | -15.671 | -16.613 | 13.177 |
Net Income Before Extra. Items | 42.594 | 0.207 | -14.335 | -15.671 | -16.613 | 13.177 |
Net Income | 42.594 | -20.293 | -22.935 | -15.671 | -16.613 | 13.177 |
Income Available to Common Excl. Extra. Items | 42.594 | 0.207 | -14.335 | -15.671 | -16.613 | 13.177 |
Income Available to Common Incl. Extra. Items | 42.594 | -20.293 | -22.935 | -15.671 | -16.613 | 13.177 |
Diluted Net Income | 42.594 | -20.293 | -22.935 | -15.671 | -16.613 | 13.177 |
Diluted Weighted Average Shares | 33.056 | 32.564 | 33.111 | 33.696 | 33.562 | 33.974 |
Diluted EPS Excluding Extraordinary Items | 1.28854 | 0.00636 | -0.43294 | -0.46507 | -0.49499 | 0.38786 |
Diluted Normalized EPS | 1.32459 | 0.0246 | 0.29794 | 0.39795 | -0.29147 | 0.50005 |
Total Extraordinary Items | -20.5 | -8.6 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 114.927 | 115.978 | 113.877 | 128.656 | 119.793 |
Revenue | 114.927 | 115.978 | 113.877 | 128.656 | 119.793 |
Cost of Revenue, Total | 48.839 | 49.577 | 46.229 | 55.613 | 54.381 |
Gross Profit | 66.088 | 66.401 | 67.648 | 73.043 | 65.412 |
Total Operating Expense | 110.407 | 109.964 | 105.332 | 123.957 | 115.612 |
Selling/General/Admin. Expenses, Total | 45.126 | 42.098 | 41.613 | 41.832 | 42.358 |
Research & Development | 15.24 | 14.249 | 14.667 | 13.85 | 13.224 |
Depreciation / Amortization | 3.897 | 3.919 | 3.681 | 3.632 | 3.598 |
Unusual Expense (Income) | -2.695 | 0.121 | -0.858 | 9.03 | 2.051 |
Operating Income | 4.52 | 6.014 | 8.545 | 4.699 | 4.181 |
Interest Income (Expense), Net Non-Operating | -1.494 | -0.543 | -0.819 | -0.884 | -0.571 |
Other, Net | -0.162 | -0.108 | -0.229 | -0.185 | -0.236 |
Net Income Before Taxes | 2.864 | 5.363 | 7.497 | 3.63 | 3.374 |
Net Income After Taxes | 2.396 | 3.464 | 5.573 | 1.744 | 1.903 |
Net Income Before Extra. Items | 2.396 | 3.464 | 5.573 | 1.744 | 1.903 |
Net Income | 2.396 | 3.464 | 5.573 | 1.744 | 1.903 |
Income Available to Common Excl. Extra. Items | 2.396 | 3.464 | 5.573 | 1.744 | 1.903 |
Income Available to Common Incl. Extra. Items | 2.396 | 3.464 | 5.573 | 1.744 | 1.903 |
Dilution Adjustment | 0 | ||||
Diluted Net Income | 2.396 | 3.464 | 5.573 | 1.744 | 1.903 |
Diluted Weighted Average Shares | 33.782 | 33.871 | 33.865 | 34.265 | 34.276 |
Diluted EPS Excluding Extraordinary Items | 0.07093 | 0.10227 | 0.16457 | 0.0509 | 0.05552 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.00419 | 0.10458 | 0.14573 | 0.17751 | 0.08927 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 405.799 | 305.628 | 285.775 | 269.749 | 271.702 | 277.291 |
Cash and Short Term Investments | 247.57 | 88.95 | 56.373 | 63.297 | 82.082 | 75.595 |
Cash & Equivalents | 213.551 | 88.95 | 56.373 | 63.297 | 82.082 | 75.595 |
Short Term Investments | 34.019 | 0 | ||||
Total Receivables, Net | 86.638 | 126.809 | 127.041 | 115.889 | 93.133 | 111.76 |
Accounts Receivable - Trade, Net | 86.638 | 126.809 | 127.041 | 115.889 | 93.133 | 111.76 |
Total Inventory | 49.587 | 71.529 | 79.736 | 71.368 | 75.65 | 67.745 |
Prepaid Expenses | 22.004 | 18.34 | 22.625 | 19.195 | 20.837 | 22.191 |
Total Assets | 649.012 | 709.919 | 638.14 | 622.527 | 600.394 | 564.288 |
Property/Plant/Equipment, Total - Net | 17.333 | 22.071 | 22.913 | 39.748 | 36.185 | 31.071 |
Property/Plant/Equipment, Total - Gross | 49.352 | 58.51 | 62.646 | 81.799 | 66.911 | 64.381 |
Accumulated Depreciation, Total | -32.019 | -36.439 | -39.733 | -42.051 | -30.726 | -33.31 |
Goodwill, Net | 113.112 | 172.998 | 147.644 | 146.367 | 151.299 | 148.657 |
Intangibles, Net | 77.165 | 172.582 | 139.453 | 114.799 | 92.741 | 65.513 |
Other Long Term Assets, Total | 35.603 | 36.64 | 42.355 | 51.864 | 48.467 | 41.756 |
Total Current Liabilities | 79.941 | 92.137 | 133.446 | 142.821 | 145.752 | 114.601 |
Accounts Payable | 18.7 | 25.242 | 28.805 | 27.253 | 23.429 | 36.405 |
Accrued Expenses | 33.735 | 40.998 | 37.465 | 50.52 | 42.663 | 44.229 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 27.506 | 25.897 | 32.176 | 29.658 | 29.246 | 33.736 |
Total Liabilities | 231.638 | 287.822 | 239.696 | 206.404 | 189.3 | 139.538 |
Total Long Term Debt | 140 | 154.283 | 69.474 | 20.264 | 6.286 | 0.23 |
Long Term Debt | 140 | 154.283 | 69.474 | 19.665 | 5.84 | 0 |
Deferred Income Tax | 3.684 | 19.407 | 16.931 | 26.581 | 21.247 | 11.811 |
Other Liabilities, Total | 8.013 | 21.995 | 19.845 | 16.738 | 16.015 | 12.896 |
Total Equity | 417.374 | 422.097 | 398.444 | 416.123 | 411.094 | 424.75 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock | 312.986 | 316.577 | 334.215 | 344.476 | 342.828 | 353.737 |
Retained Earnings (Accumulated Deficit) | 149.408 | 129.115 | 102.261 | 87.922 | 71.309 | 84.486 |
Other Equity, Total | -45.02 | -23.595 | -38.032 | -16.275 | -3.043 | -13.473 |
Total Liabilities & Shareholders’ Equity | 649.012 | 709.919 | 638.14 | 622.527 | 600.394 | 564.288 |
Total Common Shares Outstanding | 32.9202 | 33.1341 | 33.8044 | 34.1487 | 33.9117 | 34.2257 |
Current Port. of LT Debt/Capital Leases | 35 | 35.39 | 50.414 | 0.231 | ||
Capital Lease Obligations | 0.599 | 0.446 | 0.23 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 265.819 | 245.699 | 261.671 | 277.291 | 286.768 |
Cash and Short Term Investments | 80.549 | 62.494 | 68.779 | 75.595 | 84.285 |
Cash & Equivalents | 80.549 | 62.494 | 68.779 | 75.595 | 84.285 |
Total Receivables, Net | 91.326 | 92.793 | 97.37 | 111.76 | 103.714 |
Accounts Receivable - Trade, Net | 91.326 | 92.793 | 97.37 | 111.76 | 103.714 |
Total Inventory | 69.467 | 68.35 | 71.545 | 67.745 | 72.238 |
Prepaid Expenses | 24.477 | 22.062 | 23.977 | 22.191 | 26.531 |
Total Assets | 581.368 | 556.218 | 561.251 | 564.288 | 568.083 |
Property/Plant/Equipment, Total - Net | 34.058 | 34.498 | 32.783 | 31.071 | 29.418 |
Property/Plant/Equipment, Total - Gross | 63.609 | 65.284 | 64.807 | 64.381 | 63.894 |
Accumulated Depreciation, Total | -29.551 | -30.786 | -32.024 | -33.31 | -34.476 |
Goodwill, Net | 149.761 | 150.482 | 149.293 | 148.657 | 148.304 |
Intangibles, Net | 85.001 | 80.054 | 73.602 | 65.513 | 59.815 |
Other Long Term Assets, Total | 46.729 | 45.485 | 43.902 | 41.756 | 43.778 |
Total Current Liabilities | 136.476 | 102.463 | 103.801 | 114.601 | 112.855 |
Accounts Payable | 24.486 | 26.892 | 28.322 | 36.405 | 34.342 |
Accrued Expenses | 51.798 | 51.106 | 49.742 | 53.099 | 51.667 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 36.523 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 23.669 | 24.465 | 25.737 | 25.097 | 26.846 |
Total Liabilities | 172.436 | 138.391 | 138.729 | 139.538 | 137.189 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | 0 | 0 | 0 | |
Deferred Income Tax | 9.915 | 10.038 | 9.826 | 1.133 | 1.451 |
Other Liabilities, Total | 26.045 | 25.89 | 25.102 | 23.804 | 22.883 |
Total Equity | 408.932 | 417.827 | 422.522 | 424.75 | 430.894 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 344.696 | 347.818 | 350.457 | 353.737 | 359.319 |
Retained Earnings (Accumulated Deficit) | 73.705 | 77.169 | 82.742 | 84.486 | 86.389 |
Other Equity, Total | -9.469 | -7.16 | -10.677 | -13.473 | -14.814 |
Total Liabilities & Shareholders’ Equity | 581.368 | 556.218 | 561.251 | 564.288 | 568.083 |
Total Common Shares Outstanding | 34.0969 | 34.1321 | 34.1526 | 34.2257 | 34.5761 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 42.594 | -20.293 | -22.935 | -15.671 | -16.613 | 13.177 |
Cash From Operating Activities | 72.687 | 19.726 | 33.02 | 60.06 | 34.426 | 63.995 |
Cash From Operating Activities | 16.879 | 30.098 | 33.863 | 30.722 | 28.115 | 28.091 |
Deferred Taxes | -2.437 | 4.032 | -13.714 | -5.364 | -1.577 | -4.386 |
Non-Cash Items | 13.036 | 26.485 | 49.912 | 37.842 | 23.078 | 19.793 |
Cash Taxes Paid | 16.344 | 5.74 | 9.247 | 6.445 | 6.825 | 3.782 |
Cash Interest Paid | 0.041 | 4.464 | 6.169 | 4.58 | 3.11 | 1.18 |
Changes in Working Capital | 2.615 | -20.596 | -14.106 | 12.531 | 1.423 | 7.32 |
Cash From Investing Activities | -53.264 | -160.935 | -8.389 | -5.339 | -12.606 | -1.946 |
Capital Expenditures | -3.396 | -4.066 | -8.54 | -5.339 | -8.609 | -3.62 |
Other Investing Cash Flow Items, Total | -49.868 | -156.869 | 0.151 | 0 | -3.997 | 1.674 |
Cash From Financing Activities | 118.417 | 5.826 | -49.512 | -48.532 | -10.877 | -60.662 |
Financing Cash Flow Items | -5.924 | -10.372 | -5.33 | -1.689 | -3.169 | -4.107 |
Issuance (Retirement) of Stock, Net | -15.659 | 1.198 | 5.818 | 3.635 | -9.181 | 0.855 |
Issuance (Retirement) of Debt, Net | 140 | 15 | -50 | -50.478 | 1.473 | -57.41 |
Foreign Exchange Effects | -6.758 | 10.782 | -7.696 | 0.735 | 7.842 | -7.874 |
Net Change in Cash | 131.082 | -124.601 | -32.577 | 6.924 | 18.785 | -6.487 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 2.396 | 5.86 | 11.433 | 13.177 | 1.903 |
Cash From Operating Activities | 24.703 | 44.096 | 51.212 | 63.995 | 8.897 |
Cash From Operating Activities | 7.257 | 14.45 | 21.337 | 28.091 | 6.673 |
Deferred Taxes | 1.064 | 1.106 | 1.06 | -4.386 | -0.119 |
Non-Cash Items | 3.706 | 7.2 | 8.997 | 19.793 | 4.291 |
Cash Taxes Paid | -0.32 | 1.671 | 3.172 | 3.782 | 1.066 |
Cash Interest Paid | 0.513 | 0.86 | 1.065 | 1.18 | 0.114 |
Changes in Working Capital | 10.28 | 15.48 | 8.385 | 7.32 | -3.851 |
Cash From Investing Activities | -0.731 | -2.967 | -1.275 | -1.946 | -1.634 |
Capital Expenditures | -0.731 | -1.967 | -2.949 | -3.62 | -1.062 |
Cash From Financing Activities | -21.275 | -57.848 | -57.968 | -60.662 | 2.516 |
Financing Cash Flow Items | -1.15 | -1.244 | -1.254 | -4.107 | -1.228 |
Issuance (Retirement) of Stock, Net | 0 | 0.612 | 0.612 | 0.855 | 4.191 |
Issuance (Retirement) of Debt, Net | -20.125 | -57.216 | -57.326 | -57.41 | -0.447 |
Foreign Exchange Effects | -4.23 | -2.869 | -5.272 | -7.874 | -1.089 |
Net Change in Cash | -1.533 | -19.588 | -13.303 | -6.487 | 8.69 |
Other Investing Cash Flow Items, Total | -1 | 1.674 | 1.674 | -0.572 |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group +485000+
Trader
65000+
Klien aktif per bulan
$48000000+
Volume investasi per bulan
$28000000+
Coba sekarang Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Advanced Medical Equipment & Technology (NEC) |
3150 Pleasant View Road
MIDDLETON
WISCONSIN 53562
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com